Lung cancer is one of the most common, and deadly, forms of cancer. Alone, it is responsible for more deaths than breast, colorectal and prostate cancer combined. It remains a significant challenge, both in the clinical and research settings.
The key to combating cancer lies in understanding the ways it operates. Like for all cancers, early diagnosis presents the best chances of survival. Unfortunately, lung cancer often remains undiagnosed until it's too late.
For this reason, a critical component of our strategy against lung cancer is exploring how
Moreover, at the root of our significant advancements is a focus on understanding the genetics and disease pathways behind cancer. Genomic testing and advanced diagnostics can identify mutations in patients to predict the best therapy for the best possible outcomes, ultimately giving physicians and other healthcare professionals the ability to deliver truly
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
you go to an external page